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ABSTRACT Most adult mammalian skeletal muscles contain only one isoform of ryanodine receptor (RyR1), whereas
neonatal muscles contain two isoforms (RyR1 and RyR3). Membrane depolarization fails to evoke calcium release in muscle
cells lacking RyR1, demonstrating an essential role for this isoform in excitation-contraction coupling. In contrast, the role of
RyR3 is unknown. We studied the participation of RyR3 in calcium release in wild type (containing both RyR1 and RyR3
isoforms) and RyR3/ (containing only RyR1) myotubes in the presence or absence of imperatoxin A (IpTxa), a high-affinity
agonist of ryanodine receptors. IpTxa significantly increased the amplitude and the rate of release only in wild-type myotubes.
Calcium currents, recorded simultaneously with the transients, were not altered with IpTxa treatment. [3H]ryanodine binding
to RyR1 or RyR3 was significantly increased in the presence of IpTxa. Additionally, IpTxa modified the gating and conduc-
tance level of single RyR1 or RyR3 channels when studied in lipid bilayers. Our data show that IpTxa can interact with both
RyRs and that RyR3 is functional in myotubes and it can amplify the calcium release signal initiated by RyR1, perhaps through
a calcium-induced mechanism. In addition, our data indicate that when RyR3/ myotubes are voltage-clamped, the effect
of IpTxa is not detected because RyR1s are under the control of the dihydropyridine receptor.
INTRODUCTION
Ryanodine receptors (RyRs) are large tetrameric proteins
involved in calcium release from intracellular stores. To
date, three genes of RyRs have been identified (Sutko and
Airey, 1996; Sorrentino et al., 2000). Expression of the
three known RyRs varies in different tissues, suggesting
unique functional attributes of each isoform essential for
generating calcium signals (Giannini et al., 1992, 1995).
Recent studies have shown that most skeletal muscles from
adult mice contain only RyR1, with the exception of dia-
phragm, which expresses low levels of RyR3 (Conti et al.,
1996). In contrast, all skeletal muscle from neonatal mice
(Bertocchini et al., 1997) and myotubes in culture obtained
from wild-type mice (Shirokova et al., 1999) contain both
RyR1 and RyR3 isoforms.
In skeletal muscle, it is widely accepted that the RyR1 is
directly activated by the dihydropyridine receptor (DHPR)
during excitation-contraction (E-C) coupling. Previous
studies have demonstrated that several portions of the cy-
toplasmic loop connecting repeats II and III of the DHPR
1 subunit bind to RyR1 (Leong and MacLennan, 1998),
induce calcium release from the sarcoplasmic reticulum
(El-Hayek et al., 1995; El-Hayek and Ikemoto, 1998), or are
able to restore E-C coupling in dysgenic myotubes (Tanabe
et al., 1990; Nakai et al., 1998). Moreover, a specific region
of the II-III loop has been identified as the site for interac-
tion between RyR1 and DHPR in situ (Proenza et al., 2000;
Wilkens et al., 2001). The essential role of RyR1 in E-C
coupling has been further supported by the finding that
membrane depolarization fails to evoke calcium release in
muscle cells lacking RyR1 (Takeshima et al., 1994). On the
contrary, the role of RyR3 in calcium release during E-C
coupling is still uncertain. In agreement with RyR3 expres-
sion in neonatal muscles, functional studies in wild-type and
RyR3 knockout (RyR3/) mice demonstrated that con-
traction was significantly depressed in RyR3/ muscle
(Bertocchini et al., 1997). On the basis of these results, it
has been suggested that RyR3 may contribute to amplifica-
tion of calcium release generated by RyR1 (Bertocchini et
al., 1997). Although initial studies have found no differ-
ences in calcium transients recorded in the presence or
absence of RyR3 (Dietze et al., 1998), the interaction be-
tween RyR1 and RyR3 has been demonstrated by measur-
ing calcium release in the form of sparks. The properties of
sparks in RyR3/ differ from those recorded from mus-
cles containing both isoforms of RyRs (Conklin et al., 1999,
2000; Shirokova et al., 1999). In line with evidence of
functional interactions between these channels, immunolo-
calization studies have revealed that RyR1 and RyR3 are
co-localized in the triad junction (Flucher et al., 1999).
Imperatoxin A (IpTxa), a 33-amino acid peptide from the
scorpion Pandinus imperator, has high affinity for RyR1
and RyR2 and has been reported to modify RyR-channel
activity (Tripathy et al., 1998). At nanomolar concentra-
tions, IpTxa induces the appearance of long-lived subcon-
ductance states (Tripathy et al., 1998). The molecular mech-
anism of IpTxa effect is unknown, but structural studies
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(Gurrola et al., 1999) suggest that IpTxa may mimic a
portion of the II-III loop that activates RyRs. IpTxa de-
creases the amplitude and increases the duration of calcium
sparks recorded from amphibian skeletal muscle (Shtifman
et al., 2000; Gonza´lez et al., 2000), which contains both the
 and  RyR isoforms. Because the amphibian  and 
isoforms are homologous with the mammalian RyR1 and
RyR3 types, respectively (Oyamada et al., 1994), that IpTxa
may also interact with RyR3 is an attractive hypothesis.
We measured calcium transients and calcium currents in
wild-type (containing both RyR1 and RyR3 isoforms) and
RyR3/ (containing only the RyR1 isoform) myotubes in
the presence or absence of IpTxa. In wild-type myotubes,
the amplitude of calcium transients and the rate of release
were significantly increased in the presence of IpTxa,
whereas the calcium current was unaffected. The changes in
calcium transients were not observed in RyR3/ myo-
tubes. [3H]ryanodine binding to sarcoplasmic reticulum ves-
icles prepared from wild-type or RyR3/ microsomes
was significantly increased in the presence of IpTxa. Addi-
tionally, the activity of single RyR channels was recorded in
lipid bilayers. IpTxa modified the gating and conductance
level of both RyR1 and RyR3 channels. Our data show that
although IpTxa can interact with both RyR1 and RyR3
channels in single channel experiments and in [3H]ryanod-
ine binding, in intact myotubes the effects of IpTxa seem to
be mainly mediated by RyR3 channels, as myotubes from
RyR3/ mice are poorly responsive to this toxin. In
addition, the reported data are compatible with a model
where RyR1s are controlled by DHPRs in voltage-clamped
RyR3/ myotubes and, because of this interaction, IpTxa
does not modify the gating of RyR1s.
METHODS
Cell culture
Primary myoblasts were isolated from limb muscles of neonatal mice
(postnatal day 0). Mice were obtained from a colony of homozygous
RyR3-null (RyR3/; stock B6, 129P2-RyR3)(Bertocchini et al. 1997)
and from a colony of mice containing both RyR1 and RyR3 (wild type;
stock CACNA1SxNIHS-BCfBR). We have previously shown that myo-
tubes derived from wild-type mice contain both RyR1 and RyR3 using
immunofluorescence and confocal microscopy (Shirokova et al., 1999).
Muscles were finely minced and incubated for 30 min in rodent Ringer
solution (in mM: 146 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 11 glucose, 10
HEPES, pH 7.4) containing 0.3% trypsin and 0.01% DNase. The suspen-
sion was then centrifuged and filtered to remove large debris and then
plated onto 35-mm Falcon Primaria dishes (Becton Dickinson Labware,
Franklin Lakes, NJ) in plating media containing (v/v) 80% Dulbecco
modified Eagle medium with 4.5 g/l glucose, 10% horse serum, and 10%
calf serum. After 2 days, plating media was replaced with maintenance
media: 90% Dulbecco modified Eagle medium, 10% horse serum. All
cultures contained penicillin (100 U/ml) and streptomycin (100 mg/ml).
Cultures were maintained at 37°C in a 95% air/5% CO2, water-saturated
atmosphere. Myotubes were studied 7–10 days after initial plating. At this
time in culture, myotubes are multinucleated cells and contract vigorously,
either spontaneously or after electrical stimulation (Garcı´a and Beam,
1994). The size of the myotubes used in this study, as determined by cell
capacitance, varied from 130 to 280 pF.
Electrophysiology and optical recording
from myotubes
Measurements from myotubes were obtained using the patch-clamp or
lipid bilayer techniques.
Patch clamp
Transmembrane currents were recorded using the whole-cell configuration
of the patch-clamp method (Hamill et al. 1981). Patch pipettes were made
from borosilicate glass and had resistances of 1.5 to 2.1 M when filled
with internal solution (mM: 145 Cs-aspartate, 10 HEPES, 5 MgCl2, 10
Cs-EGTA, and 0.2 K5Fluo-3, pH 7.4). IpTxa was added to the internal
solution at a concentration of 10 M. The external solution contained
(mM): 145 tetraethylammonium chloride, 10 HEPES, 10 CaCl2, and 0.003
tetrodotoxin. Analog compensation was used to reduce series resistance to
charge the membrane with a time constant 1 ms. Cell capacitance, used
to calculate the membrane current density (pA/pF), was measured by
integrating the current evoked by a 10-mV hyperpolarization from a
holding potential of 80 mV. Test currents were corrected for remaining
components of linear capacitance and resistive current by digital scaling
and subtraction of the average of eight control currents (Garcı´a and Beam,
1994). L-type calcium currents were elicited with a prepulse protocol as
described in Adams et al. (1990) to inactivate other voltage-dependent
channels. In this protocol a 1-s prepulse to 30 mV is followed by a step
to50 mV for 25 ms, a 100-ms test step to potentials from40 to 60 mV,
back to 50 for 25 ms, and finally to a holding potential of 80 mV. To
construct current-voltage relationships, the experimental data were fit to a
Boltzmann equation: I(V)  GmaxL  (V  Vr)/(1  exp(VL  V)/kL)
where I(V) is the maximum calcium current at a given test potential; GmaxL
is the maximum L-type channel conductance; Vr is the reversal potential for
calcium; V is the test potential; VL is the half-maximal activation potential
for the L-type channel; and kL is the slope factor.
Calcium transients were recorded simultaneously with the currents
using Fluo-3 contained in the patch pipette. The filter combination con-
sisted of a band-pass excitation filter centered at 470 nm (half bandwidth
20 nm), a dichroic long-pass mirror centered at 510 nm, and a long-pass
emission filter centered at 520 nm. The background fluorescence for each
myotube was measured and cancelled before entering whole cell mode.
Fluorescence records are expressed as F/F, where F  Ftransient 
Fbaseline and F is Fbaseline. Baseline fluorescence is the emissions recorded
just before the start of a voltage step (Garcı´a and Beam, 1994). The calcium
transients were fit to the equation: F/F  (F/F)max/[1  exp{(VF 
V)/kF}], where (F/F)max is the maximum fluorescence change; VF is the
potential that elicits half-maximal change in fluorescence; V is the test
potential; and kF is the slope factor for the fluorescence signal.
Lipid bilayer and analysis of single-channel data
Single-channel recordings of RyRs were performed by fusing microsomes
of Chinese hamster ovary (CHO) cells expressing RyR3 or microsomes of
rabbit skeletal muscle containing RyR1 into planar lipid bilayers. A mix-
ture of phosphatidylserine: phosphatidylethanolamine (1:1 ratio), dissolved
in n-decane at a concentration of 25 mg/ml, was used to form lipid bilayer
membranes across a 250-m aperture separating the cis side from the trans
side. The cis chamber was the voltage control side whereas the trans side
was held at virtual ground. The cis (600-l) and trans (800-l) chambers
were initially filled with 50 mM Cs-methanesulfonate and 10 mM Tris/
HEPES pH 7.2. After bilayer formation, a Cs-methanesulfonate gradient
(300 mM cis/50 mM trans) was established. A Ca:EGTA mixture was then
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added to the cis chamber from a 100-fold stock to reach a desired free
[Ca2]. Free Ca2 was calculated using the Ca:EGTA constants given in
Fabiato and Fabiato (1979). Cellular microsomes were added to the cis
chamber, which corresponded to the cytoplasmic side of the channel. After
visualization of channel openings, Cs in the trans chamber was raised to
300 mM to collapse the chemical gradient and to prevent further vesicle
insertion. Data were collected at steady voltages (30 and 30 mV) for
2–5 min before and after IpTxa addition. Channel activity was recorded
with a 16-bit videocassette recorder-based acquisition and storage system
at a 10-kHz sampling rate. Signals were then analyzed after filtering with
an 8-pole Bessel filter at a frequency of 1.5–2 kHz, as described (Tripathy
et al., 1998).
[3H]ryanodine binding assays
Measurements of [3H]ryanodine binding were carried out as described
earlier (Lokuta et al., 1997; Zhu et al., 1999). Briefly, microsomes of either
wild-type or RyR3/ myotubes were incubated for 90 min at 36°C with
7 nM [3H]ryanodine in medium containing 0.2 M KCl, 10 mM Na-HEPES
(pH 7.2), and 10 M CaCl2 in the absence and the presence of IpTxa. The
microsomal protein concentration in the final reaction mixture was 30 to 50
g. Nonspecific binding, amounting to 30–40% of the total binding, was
determined in the presence of 20 M unlabeled ryanodine and has been
subtracted from the data presented. Samples (0.1 ml) were always run in
duplicate or triplicate, filtered onto glass fiber filters (Whatman GF/B or
GF/C) and washed twice with 5 ml of cold water using a Brandel M-24R
cell harvester (Gaithersburg, MD). The filters were placed in scintillation
vials and the retained radioactivity measured in a Beckman LS-5000 TD
-counter (Beckman Instruments, Fullerton, CA).
Statistics
Calcium transient and calcium current data were analyzed for statistical
significance with Statistica 5 (StatSoft, Tulsa, OK) using analysis of
variance with repeated measurements. Comparisons between binding data
groups were assessed with Origin 6.0 (Microcal Software, Northampton,
MA) using an unpaired Student’s t test. A P value  0.05 was considered
to be statistically significant.
RESULTS
Effect of IpTxa on calcium transients in
skeletal myotubes
A prepulse protocol was used to measure calcium transients
elicited by activation of DHPRs. With this protocol calcium
transients are not contaminated with calcium entry through
the T-type calcium channel (Garcı´a and Beam, 1994). Cal-
cium transients were recorded from wild-type and
RyR3/ myotubes in the absence and the presence of 10
M IpTxa. Transients from wild-type myotubes had char-
acteristics similar to those recorded from RyR3/ myo-
tubes in the absence of IpTxa, in agreement with a previous
study by Dietze et al. (1998). A representative trace of each
group of myotubes is shown in Fig. 1 A for a pulse to 20
mV. The similarity of the calcium transients between the
two groups persisted for a period of 40 min, which was the
maximum time we were able to record reliable calcium
transients from these cells. After this time, the levels of
calcium between command pulses increase substantially
and the decay of the transients becomes slower.
The amplitude of the transients increased significantly in
wild-type myotubes when the cells were perfused internally
with IpTxa. The difference in amplitude between IpTxa-
treated and -untreated wild-type myotubes was apparent as
early as 10 min after attaining whole-cell mode, suggesting
a gradual penetration of the peptide toxin into the cell. We
did not attempt to record transients before 10 min because
the calcium-sensitive dye Fluo-3 was included in the patch
pipette and it also has to diffuse into the cell. The change in
amplitude of the transient suggests that IpTxa reached, and
interacted with, RyRs by this time. In fact, the relative
increase in calcium transient amplitude became even larger
as myotubes were exposed to the toxin for longer times.
Records in Fig. 1 B show the increase in amplitude as a
function of time for a control and an IpTxa-treated wild-
type myotube. It can be seen that IpTxa increased the
calcium transient in the wild-type treated myotube despite
the rundown of the transients commonly observed in un-
treated myotubes. Thus, the increase of the calcium tran-
sient in the presence of IpTxa represents a lower limit of this
effect. The increase in calcium transient in the presence of
FIGURE 1 IpTxa enhances peak calcium transient amplitude in wild-
type but not RyR3/ myotubes. (A) Typical calcium transient wave-
forms elicited by a pulse to 20 mV from wild type (left) and RyR3 /
(right). (B) Calcium transients recorded from wild-type myotubes 10, 20,
and 30 min after entering whole-cell recording mode. Note the difference
in amplitude when comparing cells treated with IpTxa (dotted line) and
without IpTxa (continuous line). (C) Transients recorded from RyR3/
myotubes 10, 20, and 30 min after entering whole-cell recording mode.
Unlike the transients recorded from wild type, there is no difference
between cells treated with IpTxa (dotted line) and control cells (continuous
line). For both, wild-type and RyR3/ myotubes, the records in the
presence or absence of the toxin were obtained from different cells.
Calcium transients were recorded using the prepulse protocol described in
the Methods section.
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IpTxa was not present in RyR3/ myotubes. Fig. 1 C
compares calcium release in a typical control and toxin-
treated cells. It shows clearly that IpTxa does not enhance
calcium release in RyR3/ myotubes. Thus, these data
indicate that only myotubes containing the type 3 RyR
respond to internal application of IpTxa with an increase in
calcium release. The third column in Table 1 corresponds to
the maximum amplitude of the transients at 10, 20, and 30
min for the different groups of cells.
In addition to increasing the amplitude of the calcium
transient, IpTxa also caused a small but statistically signif-
icant shift of the voltage dependence of activation of the
calcium transient to more negative potentials in wild-type
myotubes but not in RyR3/. The graphs in Fig. 2 show
the voltage dependence of the calcium transient amplitude
recorded from wild-type myotubes or RyR3/ myotubes
at 10 (A), 20 (B), and 30 (C) min after entering the whole-
cell mode. Transients recorded from untreated myotubes are
represented by triangles and those recorded in the presence
of IpTxa are represented by squares. The difference in the
curves is evident for wild-type myotubes, whereas the
curves corresponding to RyR3/ myotubes overlap al-
most entirely. The average values of VF and kF for wild-type
and RyR3/ myotubes are shown in columns 4 and 5 of
Table 1. The changes observed in wild-type myotubes may
be explained by an amplification of calcium release medi-
ated by RyR3, as previously suggested by Bertocchini et al.
(1997).
IpTxa increases the rate of calcium release
We next determined the rate of calcium release by calcu-
lating the derivative of the transient with respect to time.
The derivative represents an accurate approximation of the
rate of release in myotubes because these cells have a
negligible calcium removal flux (Garcı´a and Beam, 1994),
and furthermore, as shown by Rı´os and Pizarro (1991), the
removal flux can be neglected if a large concentration of
calcium buffers is present in the sarcoplasm. In our exper-
iments, the intracellular solution contained 1 mM EGTA
and 0.2 mM Fluo-3, which represent a high concentration of
calcium buffers in these cells. In addition, Schuhmeier and
Melzer (2001) have recently validated this method for cul-
tured myotubes. Typical traces of the calcium transient
derivative for each group of myotubes are shown in Fig. 3
A. IpTxa significantly increased the value of the derivative
in wild-type myotubes, indicating a larger rate of release. In
contrast, the rate of release was not modified in RyR3/
in the presence of IpTxa. The average of the maximum
values of the derivatives is shown in column 6 of Table 1.
The graphs in Fig. 3, B–D show the voltage dependence of
the derivative at 10, 20, and 30 min of recording, respectively.
The voltage dependence of the derivative was similar in all
groups and at all times, except for the increase in amplitude of
the wild-type group treated with IpTxa. The amplitude of the
derivative in wild-type myotubes was similar to the amplitude
of untreated and IpTxa-treated RyR3/ myotubes. Thus,
these data strongly suggest that RyR3 mediates the increase in
the rate of calcium release. The lack of effect of IpTxa on
RyR1 was surprising, considering the marked effect of the
toxin on isolated RyR1 channels (Tripathy et al., 1998; Gurrola
et al., 1999). However, in current models of E-C coupling,
RyR1 is in direct contact with the voltage sensors of T-tubules.
Therefore, it is conceivable that the physical connection of
RyR1 to the voltage sensors prevents the effect of IpTxa by
hindering access to its binding site.
IpTxa does not modify L-type calcium currents
The II-III loop of 1S interacts with RyR1 (Tanabe et al.,
1990; El-Hayek et al., 1995; Nakai et al., 1996). Apart from
its well known function in triggering the release of calcium
TABLE 1 Properties of calcium transients in wild type and RyR3/ myotubes
Time Group F/Fmax kF (mV) VF (mV) d[F/F]/dtmax n
10 min Wild type 1.19 	 0.21 4.77 	 0.18 0.51 	 0.74 0.17 	 0.03 15
Wild type  IpTxa 1.94 	 0.34* 3.54 	 0.38 3.40 	 1.74* 0.27 	 0.04* 13
RyR3/ 0.99 	 0.16 6.31 	 1.32 0.10 	 1.22 0.14 	 0.02 17
RyR3/  IpTxa 1.34 	 0.23 3.57 	 0.35 1.48 	 0.54 0.17 	 0.04 13
20 min Wild type 0.68 	 0.12 4.60 	 0.26 1.06 	 0.79 0.10 	 0.02 13
Wild type  IpTxa 1.71 	 0.29* 3.74 	 0.54 4.94 	 2.19* 0.22 	 0.04* 8
RyR3/ 0.71 	 0.13 4.40 	 0.18 1.40 	 1.16 0.09 	 0.01 13
RyR3/  IpTxa 0.68 	 0.09 3.85 	 0.23 2.25 	 0.58 0.12 	 0.02 10
30 min Wild type 0.40 	 0.18 4.58 	 0.23 1.93 	 1.76 0.06 	 0.03 4
Wild type  IpTxa 1.16 	 0.20* 3.49 	 0.26 5.64 	 2.07* 0.16 	 0.03* 6
RyR3/ 0.54 4.44 2.06 0.07 2
RyR3/  IpTxa 0.40 	 0.09 3.82 	 0.20 3.51 	 2.56 0.05 	 0.01 6
Control and IpTxa-treated wild-type cells are shown at the top half of each time point; RyR3/ myotubes under control and toxin-treated conditions are
shown at the bottom half. Values in each column are averages 	 SE. n represents the number of cells examined in each group. Note that for the control
group of RyR3/ we examined only two cells and no SE is given and no comparisons were made with treated cells. The asterisk indicates that the
toxin-treated group had a statistically significant difference with the corresponding control group (P value 0.05). No statistically significant differences
were found between controls of wild-type and RyR3/ myotubes, or between control and toxin-treated RyR3/ myotubes.
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from intracellular stores, the interaction between the II-III
loop and RyR1 enhances currents through the L-type cal-
cium channel (Nakai et al., 1996). Because IpTxa may be
structurally related to an active segment of the II-III loop,
we measured L-type calcium currents in cells perfused with
the toxin and compared them with those recorded from
unperfused cells to find out whether IpTxa affects the cross-
talk between RyR1 and the L-type calcium channel.
Representative traces of calcium currents obtained at
20 mV are shown in Fig. 4 A. Calcium currents had
similar kinetics and amplitude in wild-type and RyR3/
myotubes in control conditions or in the presence of IpTxa.
Comparison of the current-voltage relationships (Fig. 4,
B–D) shows that IpTxa did not modify the voltage depen-
dence of the calcium current at any time point. The exper-
imental data were fitted as explained in the Methods section
to obtain the different parameters in columns 3–6 of Table
2. None of those parameters were different between treated
and untreated groups. Thus, our results indicate that IpTxa
alters calcium release but does not affect the RyR1-medi-
ated L-type current enhancement.
Increase of ryanodine binding by IpTxa
To determine whether the difference in calcium release
between wild type and RyR3/ in the presence of IpTxa
was attributable to a lack of interaction of the toxin in
RyR3/ myotubes, (1) microsomal preparations were
FIGURE 2 IpTxa increases calcium transient amplitude in wild-type but
not RyR3/ skeletal myotubes. A–C show the voltage dependence of the
peak calcium transient amplitude for wild type (left) and RyR3/ (right).
Transients were recorded 10 (A), 20 (B), and 30 (C) min after entering the
whole-cell configuration. The curves through the experimental data corre-
spond to the fitting of the equation described in Methods and used to obtain
the voltage dependence parameters of the transients, shown in Table 1.
Statistically significant differences (P  0.05) are denoted by an asterisk
for comparisons between treated (f) and untreated (Œ) myotubes.
FIGURE 3 IpTxa increases the amplitude of the first derivative of the
calcium transient in wild type but not in RyR3/ skeletal myotubes. A
shows the derivative of a typical calcium transient elicited by a test pulse
to 20 mV recorded from a wild-type (left) and an RyR3/ (right)
myotube. The continuous line corresponds to untreated myotubes and the
dashed line corresponds to treated cells. B–D show the voltage dependence
of the calcium transient derivative for wild type (left) and RyR3/
(right) at different times after attaining whole-cell mode. Statistically
significant differences (P  0.05) are denoted by an asterisk. Data from
control myotubes are represented by triangles, whereas the squares repre-
sent data from toxin-treated myotubes in each group.
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obtained from both types of myotubes and (2) [3H]ryanod-
ine binding was measured in the presence of IpTxa.
Microsomes were incubated for 90 min at 36°C with 7
nM [3H]ryanodine in medium containing 0.2 M KCl, 10
mM Na-HEPES (pH 7.2). At a free [Ca2] 10 nM (1 mM
EGTA and no CaCl2 added), no specific binding was de-
tected. In the presence of 10 M free [Ca2], specific
binding increased to 90–290 fmoles/mg protein. This value
represents the control [3H]ryanodine binding and was used
to normalize the binding in the presence of IpTxa for each
microsomal preparation. Normalization of [3H]ryanodine
was necessary to account for the differences in the number
of cells of each culture and thus the amount of total protein
and RyRs. Fig. 5 shows that, in the presence of IpTxa,
binding increased significantly (P  0.05) to 245 	 8.1%
(n  6) in wild-type myotubes and 238 	 8.9% (n  5) in
RyR3/ myotubes compared with control. These results
indicate that the binding properties of RyRs in wild-type
and RyR3/ myotubes are similar.
Single RyR activity recorded in lipid bilayers
Because [3H]ryanodine binding using microsomal prep-
arations does not indicate whether IpTxa modulates
RyR3 specifically, we studied the effect of IpTxa on
RyR3s, separately from RyR1s. To obtain a pure popu-
lation of RyR3s, channels were expressed in CHO cells
and subsequently isolated in microsomal vesicles. We
and others have previously shown that CHO cells do not
express detectable amounts of endogenous RyRs when
assayed by Western blots, Northern blots, or ryanodine
binding (Pan et al., 2000; Xu et al., 2000; Gurrola et al.,
1999). RyR1 channels were obtained from rabbit skeletal
muscle vesicles. The activity of the channels was re-
corded after reconstitution of the vesicles in lipid bilay-
ers. Channels were activated with 10 M free [Ca2]
added to the cis chamber (cytosolic side of the channels).
Single channel recordings are shown in Fig. 6 A. The
upper traces show the steady-state channel activity elic-
ited by Ca2. Approximately 1 min after the addition of
100 nM IpTxa to the cis chamber, a long-lived subcon-
ductance state appeared in both RyR1 and RyR3 chan-
nels. The subconductance level was 30% of the full
amplitude and is very similar to the behavior reported for
adult skeletal and cardiac RyRs (Tripathy et al., 1998)
and for frog RyRs (Shtifman et al., 2000). Bursts of
full-conductance openings, corresponding to IpTxa dis-
sociation from the channel, were regularly observed in
both channels (Fig. 6 A, lower panels). These effects of
IpTxa have been postulated to occur as a result of the
reversible binding of the toxin to a single site in the
cytoplasmic side of the channel that is different from the
ryanodine binding site (Tripathy et al., 1998). The graphs
in Fig. 6 B show the single channel amplitude as a
function of voltage. The slope of the curves, which
represents channel conductance, was less steep in the
presence of the toxin (F) compared with control (E).
This result demonstrates that IpTxa interacts with RyR3
and supports the idea that IpTxa induces a functional
modification of RyR3, which may explain the increase in
calcium release observed in wild-type myotubes.
FIGURE 4 IpTxa does not affect L-type calcium currents in skeletal
myotubes. A shows representative traces of calcium currents recorded from
wild-type (left) or RyR3/ (right) myotubes in the absence (continuous
line) or the presence (dashed line) of IpTxa. (B—D) Comparison of voltage
dependence and amplitude of calcium currents recorded from wild-type
and RyR3/ myotubes with and without IpTxa. The peak amplitude of
the calcium current is plotted as a function of voltage. Currents were
recorded 10 (B), 20 (C), and 30 (D) min after entering the whole-cell
recording mode. No statistically significant difference was found between
any group at any time. The values of maximum conductance and voltage
dependence of calcium currents are shown in Table 2. Calcium currents
were recorded simultaneously with calcium transients using a prepulse
protocol. Control values are represented by triangles and values from
toxin-treated cells are represented by squares.
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DISCUSSION
Previous studies have determined the presence of RyR1 and
RyR3 in embryonic and young animal skeletal muscles
(Bertocchini et al., 1997), where these channels are co-
localized at the junctional triad (Flucher et al., 1999). In
addition, we have previously shown that RyR1 and RyR3
are expressed in cultured myotubes obtained from wild-type
mice (Shirokova et al., 1999). Further evidence has revealed
that expression of RyR3 is necessary for optimal muscle
contraction in neonatal skeletal muscle (Bertocchini et al.,
1997) and that co-expression of RyR1 and RyR3 isoforms is
necessary to generate localized Ca2 release events in myo-
tubes (Conklin et al., 1999, 2000; Shirokova et al., 1999).
Analysis of muscle preparations from RyR3/ mice has
revealed that caffeine sensitivity is strongly decreased com-
pared with wild-type mice (Bertocchini et al., 1997; Rossi et
al., 2001). Because RyR3 channels are apparently less abun-
dant than RyR1 channels in neonatal muscles, it has been
suggested that RyR3 channels contribute to E-C coupling
through a calcium-induced calcium release mechanism,
FIGURE 5 Effect of IpTxa on the binding of [3H]ryanodine to wild-type
and RyR3 knockout microsomes. The specific binding value in the pres-
ence of 10 M free [Ca2] was 90–290 fmoles/mg protein. The specific
value represents 100% binding for each microsomal preparation and was
used to normalize the binding in the presence of 1 M IpTxa. IpTxa
increased [3H]ryanodine binding in both preparations to the same extent.
Binding was measured in the same preparation before and after the addition
of IpTxa in six cases of microsomes from wild-type myotubes and five
cases of RyR3/ microsomes.
FIGURE 6 IpTxa induces the appearance of subconductance states in
RyR1 and RyR3 channels. (A) Microsomal vesicles from rabbit skeletal
muscle (labeled RyR1) and from CHO cells expressing RyR3 (labeled
RyR3) were fused to lipid bilayers in the presence of 10 M free [Ca2]
in the cis chamber (cytosolic side of the channel) to activate RyR channels.
The upper traces in each set represent the steady-state channel activity
elicited by Ca2. The bottom traces show the same channels 
1 min after
the addition of 100 nM IpTxa to the cis (cytosolic side) chamber. Records
are representative of 15 preparations for RyR1 and 3 preparations for
RyR3. (B) Current-voltage relationships for RyR1 (left) and RyR3 (right)
in the absence of IpTxa (full conductance state; labeled control; E) and for
the IpTxa-induced subconductance state ( IpTxa; F). Slope conductance
was 0.918 and 0.244 nS for RyR1 control and IpTxa, respectively, and
0.898 and 0.239 nS for RyR3 control and IpTxa, respectively.
TABLE 2 Properties of calcium currents in wild type and RyR3-/- myotubes
Time Group GmaxL (nS/nF) kL (mV) VL (mV) Vr (mV) n
10 mins Wild type 339 	 22.6 4.7 	 0.4 9.8 	 0.8 77.1 	 1.0 15
Wild type  IpTxa 323 	 27.7 4.3 	 0.6 8.2 	 1.9 76.0 	 1.7 13
RyR3/ 314 	 15.5 4.4 	 0.3 8.8 	 0.9 74.5 	 0.8 17
RyR3/  IpTxa 258 	 35.8 4.2 	 0.7 7.7 	 1.4 78.0 	 1.7 13
20 mins Wild type 344 	 34.9 4.8 	 0.3 9.4 	 1.1 72.0 	 1.1 13
Wild type  IpTxa 319 	 30.0 4.5 	 0.3 7.0 	 2.5 74.4 	 2.2
RyR3/ 288 	 19.6 4.8 	 0.3 8.1 	 1.0 74.7 	 1.3 13
RyR3/  IpTxa 260 	 23.0 4.3 	 0.2 7.3 	 0.9 75.1 	 1.6 10
30 mins Wild type 353 	 6.1 4.1 	 0.4 5.9 	 0.8 70.2 	 1.6 4
Wild type IpTxa 345 	 59.7 4.4 	 0.5 7.6 	 2.4 75.9 	 1.5 6
RyR3/ 262 4.3 9.1 76.7 2
RyR3/  IpTxa 324 	 38.1 4.0 	 0.5 6.24 	 1.2 77.1 	 2.9 6
Calcium currents were recorded simultaneously with calcium transients using the prepulse protocol described in the Methods section. Values under each
column represent averages 	 SEM of the number of cells indicated in the last column.
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whereas RyR1 channels are mainly controlled by voltage
(Sorrentino and Reggiani, 1999). Yet, how RyR3 channels
contribute to calcium signaling in neonatal skeletal muscle
cells remains unclear.
In this paper we report that IpTxa, a high-affinity mod-
ulator of RyRs, increases the amplitude of the calcium
transient and the rate of release in myotubes containing both
RyR1 and RyR3, but not in myotubes from RyR3/ mice
which contain RyR1 only. However, IpTxa induces similar
gating changes of RyR1 and RyR3 when examined in
artificial lipid bilayers. Furthermore, IpTxa does not modify
the L-type calcium currents in either kind of myotubes.
Taken together, these results suggest that RyR1 channels in
intact myotubes are not susceptible to the stimulatory ef-
fects of IpTxa.
Because the myotubes were obtained from mice with
dissimilar genetic background, the possibility exists that the
observed differences between wild-type and RyR3/
cells was attributable to the genetic variation and not to the
presence or absence of RyR3. However, this is a remote
possibility as the proteins involved in E-C coupling are
highly conserved. Perturbations in highly conserved se-
quences would have a greater impact on cellular function
than genetic drift commonly seen in unconserved sequences
such as introns.
Although IpTxa failed to modify all the measured
parameters of calcium release in RyR3/ myotubes
(Figs. 1–3), data from [3H]ryanodine binding experi-
ments using microsomes (Fig. 5) or from analysis of
single channels reconstituted in lipid bilayers (Fig. 6)
show that IpTxa can markedly affect both RyR1 and
RyR3 channels. The lack of effect of IpTxa on RyR3/
myotubes could be explained by the tight control of
RyR1 exerted by the DHPRs. In this case, the DHPR
would command the RyR1 to open in a voltage-depen-
dent manner and independent of IpTxa binding. This idea
agrees with the fact that sparks are readily detected in
skinned mammalian muscle cells (Kirsch et al., 2001) but
not in intact, voltage-clamped adult cells or intact myo-
tubes (Shirokova et al., 1998, 1999), which suggests
RyR1 gating is under strict control of the DHPR. With
this model of control of calcium release, sparks observed
both in permeabilized (Shtifman et al., 2000; Gonza´lez et
al., 2000) or intact, voltage-clamped frog muscle cells
(Shirokova et al., 1998) could be explained by the pres-
ence of the -RyR isoform, which, as we observed in
mammalian myotubes, remains available to IpTxa ef-
fects, regardless of DHPRs. Based on the idea that RyR1
are under the control of DHPRs, our results also predict
that IpTxa would not alter calcium release in adult mam-
malian skeletal muscle cells containing RyR1 only.
When RyR1 and RyR3 were studied separately in lipid
bilayers, we found that IpTxa modified the conductance of
both channels in a strikingly similar manner (Fig. 6). Fur-
thermore, this effect was also similar to changes in gating
previously observed in RyR2 in the presence of IpTxa
(Tripathy et al., 1998), indicating a common functional
response of all known mammalian RyRs. Interestingly, the
response to IpTxa seems to be conserved between mamma-
lian and frog RyRs, because frog RyRs show similar
changes in gating (Shtifman et al., 2000). Thus, these data
support a close correspondence between mammalian and
frog RyR isoforms. These data, together with the changes
observed on calcium sparks promoted by IpTxa (increased
duration with lower amplitude), suggest that the underlying
cause for the increase in calcium transients seen in wild-
type myotubes is the longer opening of RyR3s. As all our
experiments were conducted in voltage-clamped myotubes,
it would be interesting to study the effect of IpTxa in
permeabilized RyR3/ myotubes. A hypothesis sug-
gested by our study is that in permeabilized RyR3/
myotubes, IpTxa may induce an increase of calcium sparks
frequency because RyRs are not tightly controlled by
DHPRs.
Because IpTxa increased the amplitude of the calcium
transient and the rate of release in myotubes containing
both RyR1 and RyR3, our results are compatible with an
E-C coupling model where RyR3 amplifies the calcium
signal initiated by RyR1s coupled to DHPRs. This am-
plification mechanism of calcium release is more prom-
inent during the early upstroke of the calcium transient
and decreases or inactivates with time during the course
of a voltage step. In our scheme, the contribution of this
mechanism would be absent during repolarization, thus
explaining the fact that the decay of the transients was
not modified in wild-type myotubes in the presence of
IpTxa.
Another interesting finding coming from our experi-
ments was that IpTxa did not modify the L-type calcium
currents. It has been previously shown that the coupling
between DHPRs and RyR1s enhances L-type calcium
currents (Nakai et al., 1996). In dyspedic myotubes,
which lack RyR1s, calcium currents are very small. Ex-
pression of RyR1s in dyspedic cells restores L-type cur-
rent amplitude to levels found in normal myotubes. In our
experiments, the properties of the recorded calcium cur-
rents from control or toxin-treated myotubes were simi-
lar. This suggests that IpTxa binding does not modify the
DHPR-RyR1 interaction.
Our results support the idea that muscle cells can regulate
E-C coupling through expression and assembly of different
RyRs. This effect may be mediated through sideways inter-
actions between calcium release channels (Marx et al.,
1998) or through forward interactions between DHPRs and
RyRs (Shirokova et al., 1999). Control of calcium release in
mammalian skeletal muscle is thought to be compartmen-
talized into voltage-sensitive and -insensitive sites (Shi-
rokova et al., 1998). Furthermore, it has been shown that
extrajunctional rows of RyRs form only in skeletal muscle
that expresses both RyR1 and RyR3. (Felder and Franzini-
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Armstrong, 2001). Thus, the arrangement of RyRs is af-
fected by expression of different RyR gene products. Inter-
estingly, RyR3 and RyR1/2 also have different localization
patterns in smooth muscle and distinct functions in E-C
coupling (Mironneau et al., 2001). Therefore, differential
expression and assembly of calcium release channels may
be an important mechanism regulating E-C coupling in
muscle cells.
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